Group One Trading’s Immune Design Corp. IMDZ Stock Holding History

Group One Trading’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-500	Closed	-$2K	–	5751
2017 Q4	$2K	Buy	+500	New	+$2.72K	﹤0.01%	4733
2017 Q2	–	Sell	-4,900	Closed	-$33K	–	5513
2017 Q1	$33K	Buy	+4,900	New	+$28.3K	﹤0.01%	3649
2016 Q1	–	Sell	-100	Closed	-$2K	–	5541
2015 Q4	$2K	Sell	100 -6,000	-98%	-$103K	﹤0.01%	4578
2015 Q3	$74K	Buy	+6,100	New	+$114K	﹤0.01%	3279

Group One Trading's IMDZ Position: Q2 2018 in Review

Group One Trading sold out of Immune Design Corp. (IMDZ) in Q2 2018, closing a stake of 17,594 shares — an estimated $70.1K sold.

Group One Trading first reported a position in IMDZ in Q3 2015 and held it in 7 quarters. The position peaked at $71K in Q4 2017. 80 funds tracked by Wall St. Rank hold IMDZ as of Q2 2018.

Group One Trading reported no remaining Immune Design Corp. position as of Q2 2018 after selling out during the quarter.
Group One Trading sold 17,594 Immune Design Corp. shares in Q2 2018, an estimated $70.1K.
Group One Trading first reported a position in Immune Design Corp. in Q3 2015 and held it in 7 quarters.
Group One Trading's Immune Design Corp. position peaked at $71K in Q4 2017.
80 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.